Japan's H1N1 Pandemic Prompts New Protective Mask By Unicharm
This article was originally published in PharmAsia News
Executive Summary
With Japan's H1N1 flu in a pandemic stage, Unicharm plans to launch on Sept. 28 a six-layer face mask to serve as a barrier to the disease. Demand for protective masks has surged in Japan as it faces the second wave of the disease. The mask is coated with silver ions to trap the virus and is the company's response to the rapid spread of H1N1 cases in Japan. (Click here for more - a subscription may be required
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.